CUBE vs RLAY · P/E 25, rev $1.07B vs rev $10.0M
CubeSmart (CUBE) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported RLAY revenue for 2024-12-31 was $10.0M. Net income was -$337.7M. Revenue was down 60.8% from 2023-12-31 to 2024-12-31. RLAY currently screens at market cap $3.39B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the CUBE and RLAY stock pages for the full models.
Not investment advice.